We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Capsugel Extends Inhaled Biotherapeutics Delivery Capability to Phase 2 Clinical Trials

News   May 07, 2015

 
Capsugel Extends Inhaled Biotherapeutics Delivery Capability to Phase 2 Clinical Trials
 
 
Advertisement
 

RELATED ARTICLES

Large Clinical Trial To Test Polyclonal Antibody Therapeutic for COVID-19

News

A trial evaluating a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19.

READ MORE

Fine-Tuning the Bioproduction of Drugs

News

Researchers have developed technology that allows microbes to produce drugs with feedback control systems, dialing down or amping up protein concentration as needed.

READ MORE

Encouraging Early Results From Clinical Trial of Gene Therapy for Childhood Blindness

News

According to a clinical trial, a new gene therapy for one of the most common forms of congenital blindness was safe and improved patients’ vision.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE